Starling Oncology (DFP Healthcare Acquisitions)

We are a newly-organized blank check company incorporated in November 2019. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to initially focus our search on identifying a prospective target business in the healthcare or healthcare-related industries in the United States and other developed countries. Our strategy will be to identify, acquire and, after our initial business combination, build, a healthcare or healthcare related business. We intend to focus our investment effort broadly across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics and animal health. The company was jointly founded by our management team and Deerfield Management, a healthcare investment firm with over $10 billion in regulatory assets under management as of December 31, 2019. We believe that the experience of our management team and our relationship with Deerfield Management will allow us to source, identify and execute an attractive transaction for our stockholders.